AJMC December 9, 2024
Hayden E. Klein

Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

At a recent Institute for Value-Based Medicine® event in Houston focusing on increasing value in cancer care, Bhuvana Sagar, MD, practicing oncologist, Oncology Consultants, shared her insights on the evolving role of precision medicine in oncology. In this interview, Sagar highlights the transformative potential of liquid biopsies and the challenges faced by providers and payers in getting these tests done.

Transcript

How do you see liquid biopsy technology reshaping precision medicine testing in community oncology practices?

I think liquid biopsies are great. I think previously, we only had the tissue testing. So, with tissue testing, a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, Insurance, Payer, Payment Models, Provider, Trends, Value Based
Related Articles:
How Alignment with Sound Physicians’ ACO Improved Patient Care and Outcomes
Mastering the shift to value-based care: 3 strategies for organization-wide success
CMS ending VBID model due to high costs
CMS ends value-based Medicare Advantage model: 5 things to know
CMS taps 4 states for behavioral innovation model: 5 things to know

Share This Article